(Q45884964)

17 December 2017

title

Subconjunctival gene delivery of the transcription factor GA-binding protein delays corneal neovascularization in a mouse model (English)

1 reference

17 December 2017

corneal neovascularization

1 reference

1 reference

K C Yoon

1

1 reference

17 December 2017

J A Bae

2

1 reference

17 December 2017

H J Park

3

1 reference

17 December 2017

S K Im

4

1 reference

17 December 2017

H J Oh

5

1 reference

17 December 2017

X H Lin

6

1 reference

17 December 2017

M Y Kim

7

1 reference

17 December 2017

J H Lee

8

1 reference

17 December 2017

S E Lee

9

1 reference

17 December 2017

K Y Ahn

10

1 reference

17 December 2017

K K Kim

11

1 reference

17 December 2017

publication date

7 May 2009

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

16

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

973-981

1 reference

17 December 2017

Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Corneal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Anti-angiogenic role of angiostatin during corneal wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Gene therapy for ocular neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Expression of tissue inhibitor of metalloproteinase-4 in normal human corneal cells and experimental corneal neovascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Suppression of corneal neovascularization by PEDF release from human amniotic membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Lipid-mediated delivery of brain-specific angiogenesis inhibitor 1 gene reduces corneal neovascularization in an in vivo rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

GA-binding protein transcription factor: a review of GABP as an integrator of intracellular signaling and protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

The structure of GABPalpha/beta: an ETS domain- ankyrin repeat heterodimer bound to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Regulation of E2F1-dependent gene transcription and apoptosis by the ETS-related transcription factor GABPgamma1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Identification and expression analysis of alternative transcripts of the mouse GA-binding protein (Gabp) subunits alpha and beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Brain-specific angiogenesis inhibitor 2 regulates VEGF through GABP that acts as a transcriptional repressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

The Ets transcription factor GABP is required for cell-cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

A three-kilobase fragment of the human Robo4 promoter directs cell type-specific expression in endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

roundabout4 is essential for angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Corneal avascularity is due to soluble VEGF receptor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

A GABP-binding element in the Robo4 promoter is necessary for endothelial expression in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

Angiostatin inhibits and regresses corneal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

7 January 2021

Inhibition of experimental angiogenesis of cornea by somatostatin

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

7 January 2021

Soluble Robo4 receptor inhibits in vivo angiogenesis and endothelial cell migration

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

7 January 2021

Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

7 January 2021

Effect of Octreotide on experimental corneal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

7 January 2021

Anatomy and immunology of the ocular surface

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

7 January 2021

Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.50

7 January 2021

Identifiers

DOI

10.1038/GT.2009.50

1 reference

17 December 2017

Dimensions Publication ID

1006088623

0 references

1 reference

17 December 2017